Unnecessary Psychotropic Use and Inadequate Monitoring
Summary
The facility failed to ensure one resident’s drug regimen was free from unnecessary drugs by not adequately monitoring medication side effects, not prescribing medications with an adequate or correct indication, and not frequently monitoring or re-assessing medication effectiveness. The resident had a history of dementia, alcohol abuse with alcohol-induced mood disorder, and alcohol use with alcohol-induced persisting dementia. Family reported that she had been diagnosed with early onset Alzheimer’s disease based on APOE-e4 genetic testing and had progressively worsened before admission, including wandering, forgetfulness, and behavioral changes. After transfer from the hospital, the resident was ordered Memantine and Donepezil, and the hospital also started Seroquel and Ativan for behavioral symptoms. On arrival to the facility, she was combative, verbally abusive, physically lashing out, and placed on 1:1 supervision. She received Haldol for psychosis. The prescriber later increased Ativan to compensate for alcohol withdrawal, although the record did not show when her last alcohol use occurred, how much she had been drinking, or that she was in acute withdrawal. The Ativan order was increased without a stop date, and later Depakote was started and Donepezil was discontinued without the prescriber seeing or assessing the resident that day. Seroquel was also increased later without the prescriber seeing or assessing the resident, and the resident’s chart contained nursing gaps with no notes for multiple days. The resident’s record also showed inconsistent and incomplete monitoring. Orders required staff to document side effects twice daily for Seroquel, Ativan, and Depakote, but side effect documentation was not completed as ordered and was marked with check marks instead of the required entries. Behavior monitoring entries were also inconsistent, with many days showing no behaviors or only partial documentation. The resident experienced unwitnessed falls during the stay, and later notes documented fatigue, low energy, bladder incontinence, falls, weakness, confusion, tachycardia, and weight loss. A psychiatric specialist was requested but did not see the resident until days later. By the end of the stay, the resident became acutely ill with diarrhea, fever, weakness, abnormal lung sounds, shortness of breath, and severe hypoxia, and was sent to the hospital. The medication profile also reflected concurrent use of multiple CNS drugs and psychotropics, including Ativan, Depakote, Haldol, Risperdal Consta, and Seroquel.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.